According to Vasta Platform's latest financial reports the company has $70.46 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $80.65 M | -5.67% |
2021-12-31 | $85.49 M | -44.68% |
2020-12-31 | $0.15 B | 1333.78% |
2019-12-31 | $10.77 M | -59.15% |
2018-12-31 | $26.38 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Verastem Oncology
VSTM | $0.13 B | 94.60% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $56.13 M | -20.34% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.11 B | 58.51% | ๐บ๐ธ USA |